Search Grant Opportunities

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required)

ID: PAR-18-560 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

The purpose of this Funding Opportunity Announcement (FOA) is to solicit research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials of relevance to the research mission of the National Cancer Institutes (NCI) Division of Cancer Treatment and Diagnosis (DCTD) programs. Applicants are strongly encouraged to consult the DCTD website, https://dctd.cancer.gov/, to learn more about the various program goals, research priorities and strategies developed to fight cancer. Applications submitted to this FOA must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA.

Overview

Category of Funding
Education
Health
Funding Instruments
Grant
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 1/5/18 the National Institutes of Health posted grant opportunity PAR-18-560 for National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required). The grant will be issued under grant program 93.393 Cancer Cause and Prevention Research.

Timing

Posted Date
Jan. 5, 2018, 12:00 a.m. EST
Closing Date
Nov. 12, 2020, 12:00 a.m. EST Past Due
Last Updated
Nov. 12, 2020, 2:13 p.m. EST
Version
2
Archive Date
Dec. 12, 2020

Eligibility

Eligible Applicants
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
City or township governments
Special district governments
Independent school districts
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
State governments
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Award Sizing

Ceiling
$500,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Contact Phone
(301) 496-3405

Documents

Posted documents for PAR-18-560

Grant Awards

Grants awarded through PAR-18-560

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to PAR-18-560

Experts for National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required)

Recommended subject matter experts available for hire